APOE and progression of AD–combining clinical and research data

Fawzi, Waleed, Perera, Gayan, Khondoker, Mizanur, Boitsova, Tatjana, Breen, Gerome and Stewart, Robert (2014) APOE and progression of AD–combining clinical and research data. In: 6th International Conference on Alzheimers Disease and Related Disorders in the Middle East, 2013-10-25 - 2013-10-27, Istanbul.

Full text not available from this repository. (Request a copy)


Cognitive decline in Alzheimer’s disease (AD) is inevitable, but the rate of this decline varies markedly between patients. Identifying a marker for the rate-of-decline can help in predicting prognosis and allocating resources and charting the course of care with patients and their families. Apolipoprotein E gene (APOE) is an important risk factor for late-onset AD and the presence of the genotype is the most significant genetic risk factor. However, establishing a role for APOE in predicting the rate of decline has proved elusive.

Item Type: Conference or Workshop Item (Other)
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: Pure Connector
Date Deposited: 24 Sep 2016 01:08
Last Modified: 24 Sep 2020 23:58
URI: https://ueaeprints.uea.ac.uk/id/eprint/60561
DOI: 10.1016/j.neurobiolaging.2013.10.053

Actions (login required)

View Item View Item